Sponsor or institution
Clinical trials and research at Zhengzhou University
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Zhengzhou University that are recruiting, in China. By phase: Phase 1/2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combination therapy for elderly patients with newly diagnosed diffuse large B-cell lymphoma | Phase 1/2 | Zhengzhou, Henan | Recruiting | Nov 12, 2024 |
| Using Axicabtagene Ciloleucel to improve outcomes after initial treatment for high-risk Large B-cell Lymphoma | Phase 4 | Zhengzhou, Henan | Recruiting | Sep 24, 2024 |
| Combination treatment for early stage NK/T-cell lymphoma | Phase 1/2 | Zhengzhou, Henan | Recruiting | Aug 19, 2024 |
| Using Hanlikang and BTK inhibitors to treat newly diagnosed mantle cell lymphoma | — | Zhengzhou, Henan | Recruiting | Aug 18, 2022 |
All recruiting trials (4)
-
Combination therapy for elderly patients with newly diagnosed diffuse large B-cell lymphoma
This study is testing a new combination treatment for older patients with newly diagnosed diffuse large B-cell lymphoma who can't tolerate standard chemotherapy to see if it helps them feel better and live longer.
-
Using Axicabtagene Ciloleucel to improve outcomes after initial treatment for high-risk Large B-cell Lymphoma
This study is testing if a one-time treatment with Axicabtagene Ciloleucel can help people with high-risk Large B-cell Lymphoma do better after their initial therapy.
-
Combination treatment for early stage NK/T-cell lymphoma
This study is testing a new combination treatment for early-stage NK/T-cell lymphoma to see if it helps patients feel better and is safe to use.
-
Using Hanlikang and BTK inhibitors to treat newly diagnosed mantle cell lymphoma
This study tests if a new treatment combining Hanlikang and BTK inhibitors can help people who have just been diagnosed with mantle cell lymphoma feel better.
Quick answers
How many clinical trials run by Zhengzhou University are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.